First Trust Amex Biotech Index Fund (FBT) ETF
First Trust Amex Biotech Index Fund (FBT) ETF Bio
The investment objective of the First Trust Amex Biotech Index Fund ETF seeks to measure the performance of a cross section of companies in the biotechnology industry that are primarily involved in the use of biological processes to develop products or provide services.
FBT ETF Info
| Issuer | First Trust Portfolios |
| Expense Ratio | 0.56% |
| Underlying Index | NYSE Arca Biotechnology Index |
| Asset Class | Equity |
| Sector | Health & Biotech ETFs |
| Assets Under Management (AUM) | 2.83B |
| Net Asset Value (NAV) | $144.81 |
| Options? | Yes |
| Total Holdings | 31 |
FBT Stock Chart More Charts
FBT Price/Volume Stats
| Current price | $147.15 |
| Prev. close | $144.87 |
| Day low | $145.27 |
| Day high | $147.17 |
| 50-day MA | $135.39 |
| 200-day MA | $142.48 |
| 52-week high | $159.85 |
| 52-week low | $113.43 |
| Volume | 120,700 |
| Avg. volume | 155,869 |
| Dividend yield | 0.00001% |
FBT Top Holdings
| Symbol | Company | % of Total |
| EXEL | Exelixis Inc. | 4.75% |
| IONS | Ionis Pharmaceuticals Inc. | 4.31% |
| ICPT | Intercept Pharmaceuticals Inc. | 4.15% |
| ILMN | Illumina Inc. | 3.83% |
| CRL | Charles River Laboratories International Inc. | 3.76% |
| ALNY | Alnylam Pharmaceuticals Inc. | 3.7% |
| INCY | Incyte Corporation | 3.69% |
| BIIB | Biogen Inc. | 3.61% |
| REGN | Regeneron Pharmaceuticals Inc. | 3.6% |
| GRFS | Grifols S.A. (ADR) | 3.59% |
FBT Returns
| 1-mo | 1.99% |
| 3-mo | 10.80% |
| 6-mo | -3.00% |
| 1-year | 6.29% |
| 3-year | 73.12% |
| 5-year | 82.56% |
| YTD | 18.48% |
| 2018 | -0.30% |
| 2017 | 37.07% |
| 2016 | -19.59% |
| 2015 | 10.90% |
| 2014 | 47.54% |
FBT Dividends
| Ex-Dividend Date | Type | Payout Amount | Change | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||